Annual Accounts Payable
$1.62 M
-$1.49 M-47.86%
December 31, 2023
Summary
- As of February 7, 2025, OMGA annual accounts payable is $1.62 million, with the most recent change of -$1.49 million (-47.86%) on December 31, 2023.
- During the last 3 years, OMGA annual accounts payable has risen by +$557.00 thousand (+52.40%).
- OMGA annual accounts payable is now -47.86% below its all-time high of $3.11 million, reached on December 31, 2022.
Performance
OMGA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.43 M
-$284.00 K-16.53%
September 30, 2024
Summary
- As of February 7, 2025, OMGA quarterly accounts payable is $1.43 million, with the most recent change of -$284.00 thousand (-16.53%) on September 30, 2024.
- Over the past year, OMGA quarterly accounts payable has dropped by -$145.00 thousand (-9.18%).
- OMGA quarterly accounts payable is now -77.33% below its all-time high of $6.33 million, reached on June 30, 2023.
Performance
OMGA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
OMGA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -47.9% | -9.2% |
| 3 y3 years | +52.4% | -9.2% |
| 5 y5 years | +76.7% | -9.2% |
OMGA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -47.9% | at low | -77.3% | at low |
| 5 y | 5-year | -47.9% | +76.7% | -77.3% | +57.4% |
| alltime | all time | -47.9% | +76.7% | -77.3% | +57.4% |
Omega Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.43 M(-16.5%) |
| Jun 2024 | - | $1.72 M(+8.8%) |
| Mar 2024 | - | $1.58 M(-2.5%) |
| Dec 2023 | $1.62 M(-47.9%) | $1.62 M(-32.6%) |
| Sep 2023 | - | $2.40 M(-62.0%) |
| Jun 2023 | - | $6.33 M(+72.0%) |
| Mar 2023 | - | $3.68 M(+18.4%) |
| Dec 2022 | $3.11 M | $3.11 M(+21.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $2.57 M(-6.0%) |
| Jun 2022 | - | $2.73 M(+33.2%) |
| Mar 2022 | - | $2.05 M(-2.8%) |
| Dec 2021 | $2.11 M(+98.4%) | $2.11 M(+131.5%) |
| Sep 2021 | - | $911.00 K(-22.1%) |
| Jun 2021 | - | $1.17 M(-65.1%) |
| Mar 2021 | - | $3.35 M(+215.4%) |
| Dec 2020 | $1.06 M(+15.9%) | $1.06 M |
| Dec 2019 | $917.00 K | - |
FAQ
- What is Omega Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Omega Therapeutics?
- What is Omega Therapeutics annual accounts payable year-on-year change?
- What is Omega Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Omega Therapeutics?
- What is Omega Therapeutics quarterly accounts payable year-on-year change?
What is Omega Therapeutics annual accounts payable?
The current annual accounts payable of OMGA is $1.62 M
What is the all time high annual accounts payable for Omega Therapeutics?
Omega Therapeutics all-time high annual accounts payable is $3.11 M
What is Omega Therapeutics annual accounts payable year-on-year change?
Over the past year, OMGA annual accounts payable has changed by -$1.49 M (-47.86%)
What is Omega Therapeutics quarterly accounts payable?
The current quarterly accounts payable of OMGA is $1.43 M
What is the all time high quarterly accounts payable for Omega Therapeutics?
Omega Therapeutics all-time high quarterly accounts payable is $6.33 M
What is Omega Therapeutics quarterly accounts payable year-on-year change?
Over the past year, OMGA quarterly accounts payable has changed by -$145.00 K (-9.18%)